Related references
Note: Only part of the references are listed.Prognostic value of Waldeyer's ring involvement of diffuse large B-cell lymphoma treated with R-CHOP
Min-Young Oh et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Clinical value of metabolic tumor volume by PET/CT in extranodal natural killer/T cell lymphoma
Moo-Kon Song et al.
LEUKEMIA RESEARCH (2013)
Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement
Moo-Kon Song et al.
ANNALS OF HEMATOLOGY (2012)
Prognostic value of metabolic tumor volume on PET?/?CT in primary gastrointestinal diffuse large B cell lymphoma
Moo-Kon Song et al.
CANCER SCIENCE (2012)
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
The international harmonization project for response criteria in lymphoma clinical trials
Bruce D. Cheson
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma:: Final results of the GHSG HD7 trial
Andreas Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Second malignancy risk associated with treatment of Hodgkin's lymphoma:: meta-analysis of the randomised trials
J. Franklin et al.
ANNALS OF ONCOLOGY (2006)
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma:: Long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials
Evert M. Noordijk et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
M Hutchings et al.
BLOOD (2006)
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
M Hutchings et al.
ANNALS OF ONCOLOGY (2005)
The EORTC strategy in the treatment of Hodgkin's lymphoma
H Eghbali et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
FDG-PET/CT in re-staging of patients with lymphoma
LS Freudenberg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
DJ Straus et al.
BLOOD (2004)
Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy:: results after 7 years of a prospective study
AR Domínguez et al.
ANNALS OF ONCOLOGY (2004)
Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease
R Munker et al.
ANNALS OF ONCOLOGY (2004)
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma
PG Gobbi et al.
CANCER (2004)
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
A Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger
AK Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease
MR Weihrauch et al.
ANNALS OF HEMATOLOGY (2002)
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma
A Wirth et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Share Paper
